Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TROFOSFAMIDE: 109 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
109
Total FAERS Reports
19 (17.4%)
Deaths Reported
35
Hospitalizations
109
As Primary/Secondary Suspect
5
Life-Threatening

First Report: 2009 · Latest Report: 20221007

What Are the Most Common TROFOSFAMIDE Side Effects?

#1 Most Reported
Myelodysplastic syndrome
18 reports (16.5%)
#2 Most Reported
Acute myeloid leukaemia
18 reports (16.5%)
#3 Most Reported
Product use in unapproved indication
16 reports (14.7%)

All TROFOSFAMIDE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Acute myeloid leukaemia 18 16.5% 9 1
Myelodysplastic syndrome 18 16.5% 9 1
Product use in unapproved indication 16 14.7% 0 2
Off label use 15 13.8% 2 1
Neutropenia 14 12.8% 1 6
Anaemia 13 11.9% 0 0
Dyspnoea 12 11.0% 0 7
Oedema 10 9.2% 0 0
Pleural effusion 10 9.2% 0 5
Hepatosplenomegaly 9 8.3% 0 0
Hyperleukocytosis 9 8.3% 1 0
Rhabdomyosarcoma recurrent 9 8.3% 2 0
Thrombocytopenia 9 8.3% 0 0
Neoplasm progression 8 7.3% 2 0
Acute kidney injury 7 6.4% 1 5
Alanine aminotransferase increased 7 6.4% 0 6
Chromosome analysis abnormal 7 6.4% 0 0
Haemoglobin decreased 7 6.4% 0 6
Neuropathy peripheral 7 6.4% 0 6
Pneumonia fungal 7 6.4% 0 0

Who Reports TROFOSFAMIDE Side Effects? Age & Gender Data

Gender: 36.5% female, 63.5% male. Average age: 55.1 years. Most reports from: DE. View detailed demographics →

Is TROFOSFAMIDE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2009 11 3 2
2012 3 0 1
2013 5 0 4
2014 7 3 7
2015 5 0 5
2016 1 0 1
2018 7 0 2
2019 9 1 7
2020 5 0 5
2021 1 1 0
2022 1 0 0

View full timeline →

What Is TROFOSFAMIDE Used For?

IndicationReports
Metastatic malignant melanoma 32
Diffuse large b-cell lymphoma 13
Alveolar rhabdomyosarcoma 12
Langerhans' cell histiocytosis 11
Angioimmunoblastic t-cell lymphoma 6
Product used for unknown indication 6
Hodgkin's disease 5
Lymphoma 5

TROFOSFAMIDE vs Alternatives: Which Is Safer?

TROFOSFAMIDE vs TROPATEPINE TROFOSFAMIDE vs TROPICAMIDE TROFOSFAMIDE vs TROSPIUM TROFOSFAMIDE vs TROSPIUM\XANOMELINE TROFOSFAMIDE vs TRUVADA TROFOSFAMIDE vs TRYPTOPHAN TROFOSFAMIDE vs TUBERCULIN PURIFIED PROTEIN DERIVATIVE TROFOSFAMIDE vs TUCATINIB TROFOSFAMIDE vs TUCIDINOSTAT TROFOSFAMIDE vs TYKERB

Official FDA Label for TROFOSFAMIDE

Official prescribing information from the FDA-approved drug label.